Abstract
Background Acute ischemic stroke caused by large-vessel occlusion is effectively treated by endovascular treatment (EVT). However, treatment could be further refined by improved understanding of the underlying pathophysiology, including dynamic cerebral autoregulation (dCA). Near-infrared spectroscopy (NIRS) requires virtually no setup time and enables dCA investigation during EVT by measuring dynamic concentration in cortical oxygenated hemoglobin (OxyHb) continuously.
Methods The aim was to investigate dCA during EVT, before and after recanalization, and at follow-up after 24 hours and 90 days. We applied interhemispheric transfer function analysis of low-frequency (LF) oscillations (0.07-0.2 Hz) in OxyHb that yields the dCA measures, gain and phase shift. Mixed-effect models were used to examine dCA over time. We then predicted outcome by dCA in multivariate logistic regression models.
Results We found higher LF gain in patients with favorable outcome. While dCA was stable for most patients during EVT, LF phase shift increased immediately after recanalization for patients with milder symptom severity and at 24-hour follow-up for patients with more severe symptoms. Adjusted for age, infarct size before EVT, and recanalization success, average LF gain predicted independent functional outcome, symptom severity and mortality at 90-day follow-up.
Conclusions Interhemispheric transfer function analysis based on NIRS provides insights into dCA changes during EVT that could potentially be applied in the development of individualized treatment. The method relies on intact contralateral dCA which needs further investigations. The potential of dCA to strengthen prediction models also warrant additional examination.
Clinical Trial Registration ClinicalTrial.gov: NCT03738644. https://clinicaltrials.gov/study/NCT03738644.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ClinicalTrials.gov: NCT03738644
Funding Statement
The study was supported by Simon Fougner Hartmanns Family Foundation, Gangsted Foundation, Sophus Jacobsen Foundation and Rigshospitalet?s Research Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Scientific Ethics Committees for the Capital Region of Denmark (H-18028704)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Non-standard Abbreviations and Acronyms
- ABP
- Arterial Blood Pressure
- ACA
- Anterior Cerebral Artery
- AIS
- Acute Ischemic Stroke
- ASPECTS
- Alberta Stroke Program Early CT Score
- BA
- Basilar artery.
- CW-NIRS
- Continuous Wave Near-Infrared Spectroscopy
- dCA
- Dynamic Cerebral Autoregulation
- DeoxyHb
- Deoxygenated Hemoglobin Concentration
- EVT
- Endovascular Treatment
- FU
- Follow-up
- FU24-group
- All participants with sufficient data at PRE, POST and 24-hour FU.
- FU90-group
- All patients with sufficient data at PRE, POST, 24-hour and 90-day FU.
- HF
- High-frequency (0.2-0.5 Hz)
- ICA
- Internal carotid artery.
- IVT
- Intravenous thrombolysis.
- LF
- Low-frequency (0.07-0.2 Hz)
- LFO
- Low-frequency oscillations
- LVO
- Large-vessel Occlusion
- M1
- First part of middle cerebral artery.
- M2
- Second part of middle cerebral artery.
- MCA
- Middle Cerebral Artery
- mRS
- modified Rankin Scale
- mTICI
- Modified Treatment In Cerebral Infarction
- NIHSS
- National Institutes of Health Stroke Scale
- NIRS
- Near-Infrared Spectroscopy
- OxyHb
- Oxygenated Hemoglobin Concentration
- PC-ASPECTS
- Posterior circulation Alberta Stroke Program Early CT Score
- PCA
- Posterior cerebral artery.
- POST
- Second time segment (after achieving final reperfusion status)
- PRE
- First time segment (after sedation but before any attempted revascularization)
- PSD
- Power spectral
- STROBE
- STrengthening the Reporting of OBservational studies in Epidemiology
- TFA
- Transfer Function Analysis
- TIA
- Transient ischemic attack
- VLF
- Very low-frequency (0.02-0.07 Hz).
- VMCA
- Flow velocity in the Middle Cerebral Artery
